Search Results - "Haseda, F."

Low programmed cell death‐1 (PD‐1) expression in peripheral CD4+ T cells in Japanese patients with autoimmune type 1 diabetes by Fujisawa, R., Haseda, F., Tsutsumi, C., Hiromine, Y., Noso, S., Kawabata, Y., Mitsui, S., Terasaki, J., Ikegami, H., Imagawa, A., Hanafusa, T.

“…Summary Programmed cell death‐1 (PD‐1) is a co‐stimulatory molecule that inhibits T cell proliferation. We aimed to clarify PD‐1 expression in CD4+ T cells and…”
Get full text

CD4+CD45RA−FoxP3high activated regulatory T cells are functionally impaired and related to residual insulin‐secreting capacity in patients with type 1 diabetes by Haseda, F., Imagawa, A., Murase‐Mishiba, Y., Terasaki, J., Hanafusa, T.

“…Summary Accumulating lines of evidence have suggested that regulatory T cells (Tregs) play a central role in T cell‐mediated immune response and the…”
Get full text

Benefit of Early Add-on of Linagliptin to Insulin in Japanese Patients With Type 2 Diabetes Mellitus: Randomized-Controlled Open-Label Trial (TRUST2) by Katsuno, Tomoyuki, Shiraiwa, Toshihiko, Iwasaki, Shingo, Park, Hyohun, Watanabe, Nobuaki, Kaneko, Shizuka, Terasaki, Jungo, Hanafusa, Toshiaki, Imagawa, Akihisa, Shimomura, Iichiro, Ikegami, Hiroshi, Koyama, Hidenori, Namba, Mitsuyoshi, Miyagawa, Jun-ichiro

“…Introduction This trial was conducted to assess the long-term safety, efficacy, and benefit of early add-on of linagliptin to insulin in patients with type 2…”
Get full text

Low programmed cell death-1 (PD-1) expression in peripheral CD4 super(+) T cells in Japanese patients with autoimmune type 1 diabetes by Fujisawa, R, Haseda, F, Tsutsumi, C, Hiromine, Y, Noso, S, Kawabata, Y, Mitsui, S, Terasaki, J, Ikegami, H, Imagawa, A, Hanafusa, T

“…Programmed cell death-1 (PD-1) is a co-stimulatory molecule that inhibits T cell proliferation. We aimed to clarify PD-1 expression in CD4(+) T cells and the…”
Get full text